114 related articles for article (PubMed ID: 2554626)
1. [Delayed hypersensitivity to the antigens of the herpes simplex virus and herpetic resistance induced in mice by the administration of xenogeneic lymphocytic ultrafiltrates].
Mats AN; Pozdniakov VI; Volkova MA; Perelygina OV; Perepechkina NP
Zh Mikrobiol Epidemiol Immunobiol; 1989 Jul; (7):93-6. PubMed ID: 2554626
[TBL] [Abstract][Full Text] [Related]
2. Delayed hypersensitivity and immune protection against herpes simplex virus: suppressor T cells that regulate the induction of delayed hypersensitivity effector T cells also regulate the induction of protective T cells.
Schrier RD; Ishioka GY; Pizer LI; Moorhead JW
J Immunol; 1985 May; 134(5):2889-93. PubMed ID: 2580006
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediated immunity in herpes simplex virus-infected mice: H-2 mapping of the delayed-type hypersensitivity response and the antiviral T cell response.
Nash AA; Phelan J; Wildy P
J Immunol; 1981 Apr; 126(4):1260-2. PubMed ID: 6259256
[TBL] [Abstract][Full Text] [Related]
4. Immunity to herpes simplex virus type 2. Suppression of virus-induced immune responses in ultraviolet B-irradiated mice.
Yasumoto S; Hayashi Y; Aurelian L
J Immunol; 1987 Oct; 139(8):2788-93. PubMed ID: 2821119
[TBL] [Abstract][Full Text] [Related]
5. Split T-cell tolerance in herpes simplex virus-infected mice and its implication for anti-viral immunity.
Nash AA; Ashford NP
Immunology; 1982 Apr; 45(4):761-7. PubMed ID: 6279490
[TBL] [Abstract][Full Text] [Related]
6. Electron microscopic study on the role of delayed hypersensitivity & antibody producing cells in protection against herpes simplex virus in nude mice.
Kapoor AK; Nath P; Nash AA; Tandon P; Khan IU
Indian J Med Res; 1987 Feb; 85():120-4. PubMed ID: 3036694
[No Abstract] [Full Text] [Related]
7. Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection.
Rager-Zisman B; Allison AC
J Immunol; 1976 Jan; 116(1):35-40. PubMed ID: 173758
[TBL] [Abstract][Full Text] [Related]
8. Protective immunization of mice with specific HSV-1 glycoproteins.
Chan WL
Immunology; 1983 Jun; 49(2):343-52. PubMed ID: 6303950
[TBL] [Abstract][Full Text] [Related]
9. Prospects for vaccines for herpes simplex viruses.
Berman PW
J Am Acad Dermatol; 1988 Jan; 18(1 Pt 2):226-30. PubMed ID: 2828443
[TBL] [Abstract][Full Text] [Related]
10. Transcutaneous immunisation with herpes simplex virus stimulates immunity in mice.
El-Ghorr AA; Williams RM; Heap C; Norval M
FEMS Immunol Med Microbiol; 2000 Dec; 29(4):255-61. PubMed ID: 11118905
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide-induced suppressor cells for delayed-type hypersensitivity to herpes simplex virus: nature of suppressor cell and effect on pathogenesis of herpes simplex.
Altmann DM; Blyth WA
Immunology; 1984 Nov; 53(3):473-80. PubMed ID: 6092271
[TBL] [Abstract][Full Text] [Related]
12. Yeast-derived glycoprotein B-1 of herpes simplex virus (HSV) as a candidate for an HSV vaccine.
Kino Y
Adv Exp Med Biol; 1990; 278():183-90. PubMed ID: 1963033
[No Abstract] [Full Text] [Related]
13. Humoral and cellular immune responses to an envelope-associated antigen of herpes simplex virus.
Zaia JA; Palmer EL; Feorino PM
J Infect Dis; 1975 Dec; 132(6):660-6. PubMed ID: 172562
[TBL] [Abstract][Full Text] [Related]
14. Role of suppressor T cells in herpes simplex virus-induced immune deviation.
Whittum JA; Niederkorn JY; McCulley JP; Streilein JW
J Virol; 1984 Aug; 51(2):556-8. PubMed ID: 6086965
[TBL] [Abstract][Full Text] [Related]
15. Tolerance and immunity in mice infected with herpes simplex virus: studies on the mechanism of tolerance to delayed-type hypersensitivity.
Nash AA; Phelan J; Gell PG; Wildy P
Immunology; 1981 Jun; 43(2):363-9. PubMed ID: 6265348
[TBL] [Abstract][Full Text] [Related]
16. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens.
Karem KL; Bowen J; Kuklin N; Rouse BT
J Gen Virol; 1997 Feb; 78 ( Pt 2)():427-34. PubMed ID: 9018066
[TBL] [Abstract][Full Text] [Related]
17. Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection.
Chan WL; Lukig ML; Liew FY
J Exp Med; 1985 Oct; 162(4):1304-18. PubMed ID: 2995536
[TBL] [Abstract][Full Text] [Related]
18. Type-specific delayed hypersensitivity and protective immunity induced by isolated herpes simplex virus glycoprotein.
Schrier RD; Pizer LI; Moorhead JW
J Immunol; 1983 Mar; 130(3):1413-8. PubMed ID: 6185584
[No Abstract] [Full Text] [Related]
19. Immune response to synthetic herpes simplex virus peptides: the feasibility of a synthetic vaccine.
Heber-Katz E; Dietzschold B
Curr Top Microbiol Immunol; 1986; 130():51-64. PubMed ID: 3022991
[No Abstract] [Full Text] [Related]
20. Evaluation of antiviral immunity using vaccinia virus recombinants expressing cloned genes for herpes simplex virus type 1 glycoproteins.
Martin S; Cantin E; Rouse BT
J Gen Virol; 1989 Jun; 70 ( Pt 6)():1359-70. PubMed ID: 2543783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
